환자 정보 전단
Date revised: 18.08.2016
Print date: 02.06.17
2 / GB- 800337-001-01
Version: 2 / GB
Replaces Version: 1 /
GB
SAFETY DATA SHEET IN ACCORDANCE WITH REGULATION (EC) NO
1907/2006 NEODISHER SYSTEMACT
Page 1(10)
SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE
COMPANY/UNDERTAKING
1.1. PRODUCT IDENTIFIER
neodisher SystemAct
1.2. RELEVANT IDENTIFIED USES OF THE SUBSTANCE OR MIXTURE AND USES
ADVISED AGAINST
USE OF THE SUBSTANCE/PREPARATION
Washing and cleaning products (including solvent based products)
1.3. DETAILS OF THE SUPPLIER OF THE SAFETY DATA SHEET
ADDRESS:
Chemische Fabrik Dr. Weigert GmbH & Co. KG
Mühlenhagen 85
D-20539 Hamburg
Telephone no.
+49 40 789 60 0
Fax no.
+49 40 789 60 120
www.drweigert.com
E-MAIL ADDRESS OF PERSON RESPONSIBLE FOR THIS SDS:
sida@drweigert.de
1.4. EMERGENCY TELEPHONE NUMBER
GBK/ Infotrac: (USA domestic) 1 800 535 5053 or international +1 352
323 3500
SECTION 2: HAZARDS IDENTIFICATION
2.1. CLASSIFICATION OF THE SUBSTANCE OR MIXTURE
This product is not classified hazardous in accordance with Regulation
(EC) No 1272/2008.
2.2. LABEL ELEMENTS
LABELLING ACCORDING TO REGULATION (EC) NO 1272/2008
HAZARD STATEMENTS
EUH210
Safety data sheet available on request.
HAZARDOUS COMPONENT(S) TO BE INDICATED ON LABEL (REGULATION (EC) NO.
1272/2008)
EUH208 Contains
subtilisin, cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane
chloride, 4-
formylphenylboronic acid, May produce an allergic reaction.
2.3. OTHER HAZARDS
No special hazards have to be mentioned.
SECTION 3: COMPOSITION/INFORMATION ON INGREDIENTS
3.2. MIXTURES
HAZARDOUS INGREDIENTS
SODIUM CUMENESULFONATE
CAS No.
15763-76-5
EINECS no.
239-854-6
Registration no.
01-2119489411-37
Concentration
>=
1
<
10
%
Classification (Regulation (EC) No. 1272/2008)
Eye Irrit. 2
H319
Date revised: 18.08.2016
Print date: 02.06.17
2 / GB- 800337-001-01
Version: 2 / GB
Replaces Version: 1 /
GB
SAFETY DATA SHEET IN ACCORDANCE WITH REGULATION (EC) NO
1907/2006 NEODISHER SYSTEMACT
Page 2(10)
FATTY ALCOHOLS, ALKOXYLATED
CAS No.
120313-48-6
Concentratio
전체 문서 읽기
제품 특성 요약
Enzymatic cleaning component
for reprocessing thermostable
and thermolabile instruments
Highly concentrated liquid
WWW.DRWEIGERT.COM
neodisher
®
SystemAct
Fields of application:
Automated cleaning of surgical instruments, incl. MIS
instruments and micro instruments, anaesthesia utensils,
containers and other medical utensils
Performance spectrum:
Enzymatic cleaning component which is dosed together
with the mildly alkaline cleaning component
NEODISHER
SYSTEMCLEAN
into the cleaning step of the washer
disinfector. The resulting enzymatic alkaline solution has
the following properties:
•
Reliably removes residues of dried and denatured
blood; at the same time exhibiting excellent material
compatibility
•
Fulfils the current recommendations of the Robert
Koch Institute (RKI) for reprocessing medical devices
for minimizing the risk of transmitting the new variant
of the Creutzfeldt Jakob Disease (vCJD)
•
Suitable for instruments and utensils made of
stainless steel, instrument steel, anodized aluminium,
optics, commonly used synthetic materials and
materials of anaesthesia utensils
•
Excellent compatibility with anodized aluminium when
dosed according to individual requirements
Special properties:
•
Component concentrations can be individually chosen
to meet the requirements, depending on soiling
•
Highly concentrated liquid: maximum efficiency
•
Excellent material compatibility
•
Low-foam formula
•
First-class cleaning performance due to the
individually adaptable combination of alkali and
enzyme components
•
No neutralization step necessary with automated
reprocessing, therefore short program cycles
•
Exempt from classification: no hazardous substance,
no hazardous product
•
Fitted with RFID transponder for automatic product
identification with the weigomatic system ALPHA
component dosing system to safely exclude product
mix-ups
Application and dosage:
The cleaning components NEODISHER SYSTEMCLEAN
and NEODISHER SYSTEMACT are used in washer
disinfectors. The dosing amount also depends on the
전체 문서 읽기
환자 정보 전단 